Exchange: NASDAQ·Updated 07:59 PM EDT
SKYE logo

SKYE Skye Bioscience Inc

$1.86
$0.08
(4.49%)
Today
Closed $1.86
$0.05
(2.69%)
After Hours
Reported EarningsAug 14
Mkt Cap$8.24M
Vol183,113.00

About SKYE

Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.
40

Bearish Sentiment

How do you feel about SKYE?

Advertisement|Remove ads.